Frost – Tamfis

Frost & Sullivan grants the Global Targeted Molecular Fluorescent Tracer R&D Leadership Award to Nanjing Nuoyuan Medical Devices Co., Ltd., Business News

Business new tamfitronics

Shanghai, China – September 9, 2024 —

Frost & Sullivan is pleased to announce that the 18th Growth Innovation Leadership (GIL) Summit and the 3rd New Investment Event (NIE 2024), was held in Shanghai from August 27 to 30, 2024, co-hosted by LeadLeo.

Based on research and analysis of the global targeted molecular fluorescent tracer market, as well as studies and evaluations of relevant companies in the industry, Frost & Sullivan has awarded Nanjing Nuoyuan Medical Devices Co., Ltd. the Global Targeted Molecular Fluorescent Tracer R&D Leadership Award at the GIL Summit and NIE 2024. Mr. Aroop Zutshi, the Global Managing Partner and Executive Board Member of Frost & Sullivan, and Professor Yu Wang, the Chairman of Chinese Foundation for Hepatitis Prevention and Control and the Former Director General of Chinese Center for Disease Control and Prevention presented this award to Mr. Huiming Cai, Chairman and President of Nanjing Nuoyuan Medical Devices Co., Ltd.

Frost & Sullivan grants Nanjing Nuoyuan Medical Devices Co., Ltd. the “GLOBAL TARGETED MOLECULAR FLUORESCENT TRACER R&D LEADERSHIP AWARD”

[Image of On-site Award Ceremony]

Mr. Aroop Zutshi, the Global Managing Partner and Executive Board Member of Frost & Sullivan, and Professor Yu Wang, the Chairman of Chinese Foundation for Hepatitis Prevention and Control and the Former Director General of Chinese Center for Disease Control and Prevention presented this award to Mr. Huiming Cai, Chairman and President of Nanjing Nuoyuan Medical Devices Co., Ltd.

Nuliferay aims to become a leader in precision medical technology

Nanjing Nuoyuan Medical Devices Co., Ltd. (Nuliferay) is a Chinese national high-tech enterprise integrating R&D, production, and sales of high-end medical devices and innovative targeted probes. The company has established an innovative model of “dual-track of medicine and equipment” development to provide full-chain solutions for precise oncology diagnosis and treatment. Nuliferay possesses ongoing innovation capabilities, develops multiple series of internationally advanced medical devices and contrast agents, and focuses on core technologies such as molecular fluorescence, Raman spectroscopy, artificial intelligence, and AI-assisted drug design. The company aims to become a leader in precision medical technology.

Under the “dual-track” development model, Nuliferay is developing innovative targeted fluorescence probe products

Nuliferay has developed multiple high-end fluorescence endoscopes, including surgical fluorescence imaging systems, 4K endoscopic fluorescence imaging systems, and the innovative “4K 3D endoscopic fluorescence imaging system.” Additionally, they are working on the “AI-assisted Raman spectroscopy molecular fluorescence multi-modal navigation system” as part of a major Chinese national research project.

Nuliferay’s “dual-track” strategy involves strengthening endoscope device technology while also advancing research and clinical application of molecular targeted probes associated with fluorescence endoscopes. Currently, the company is developing a series of innovative targeted fluorescent probe products. The related research achievements have been rapidly transformed and published in authoritative journals such as Cell Reports Physical Science (a sub-journal of Cell), Biosensors and Bioelectronics, Sensors and Actuators B-Chemical, and Chinese Journal of Academic Radiology. The company holds nearly twenty patents related to the structures, clinical applications, and impurities, establishing a solid technical barrier for subsequent development and application. With the advancements in endoscopic equipment and molecular targeted fluorescent probes, it is expected to further enhance the precision of oncological surgeries at the molecular level.

Nuliferay’s targeted fluorescent probes is revolutionizing the navigation technology in fluorescence-guided surgery, and creating a path to international markets

Nuliferay is committed to leading the innovation process of China’s medical endoscopy industry. Since its establishment in 2011, the company has undertaken more than ten national and provincial key research projects, including the “National 13th Five-Year Plan Key Research and Development Program,” “National Major Scientific Research Instrument Development Project,” “National Ministry of Industry and Information Technology’s Artificial Intelligence Medical Device Innovation Task Unveiling,” and “Jiangsu Province Key Core Technology Research Project.” In 2023, Nuliferay was recognized as a “Specialized, Refined, Differentiated, and Innovative” enterprise in Jiangsu Province by the Jiangsu Provincial Department of Industry and Information Technology.

Nuliferay’s series of targeted fluorescence probe products are aimed at multiple typical tumor receptors, significantly improving the precision and efficacy of tumor treatment and reducing false-positive rates. The company’s research pipeline includes six series of products: folate receptor (FR), epidermal growth factor receptor (EGFR), mesenchymal-epithelial transition factor (cMET), vascular endothelial growth factor receptor (VEGFR), passive targeting broad-spectrum types, and neural imaging types. Nuliferay is also promoting the international market expansion of its best-in-class folate receptor (FRα) targeted probe NY-FR-07.

About Frost & Sullivan’s Global Leadership Award

The Frost & Sullivan Global Leadership Award recognizes enterprises’ outstanding performance and exceptional achievements in areas such as technology innovation, market potential, customer service, branding, and others. The Frost & Sullivan team nominated a group of competitive and excellent enterprises through methods including in-depth interviews, industry analysis, and secondary research. An independent judging panel, made up of third-party investment and financing experts, financial experts, bankers, and renowned listed company entrepreneurs, conducted rigorous evaluations of the nominated enterprises and decided to grant the 2024 Global Targeted Molecular Fluorescent Tracer R&D Leadership Award to Nanjing Nuoyuan Medical Devices Co., Ltd.

Contact Info:
Name: Qian Li
Email: Send Email
Organization: Frost & Sullivan
Website: http://www.frostchina.com

Release ID: 89140622

If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release that require attention or if there is a need for a press release takedown, we kindly request that you notify us without delay at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or guide you through the removal process. Ensuring accurate and reliable information is fundamental to our mission.

AeC Known by Frost & Sullivan for Leading the Buyer Relationship Industry in Brazil, Business News

Business new tamfitronics

AeC is the biggest buyer relationship firm in Brazil and its reliable and custom-made buyer care solutions aid businesses build seamless stop-user experiences.

SAN ANTONIO, March 29, 2024 /PRNewswire/ — Frost & Sullivan recently researched the customer skills outsourcing products and companies industry and, in preserving with its findings, acknowledges AeC with the 2023 Company of the 365 days Award. AeC is connecting skills with prominent buyer carrier to amplify efficiency and optimize the customer’s industry dart. AeC leverages synthetic intelligence (AI), info intelligence, machine learning (ML), natural language processing (NLP), fraud prevention, and true human experiences to make sure an optimal buyer skills (CX) in its consumers’ industry operations.

The firm helps businesses carry a excellent CX to live aggressive within the marketplace and meet its consumers’ demands. It repeatedly targets to spice up stop-user CX by fastidiously analyzing buyer info, testing unusual industry units, and adjusting its processes in preserving with buyer feedback.

AeC drives its consumers’ digital transformations with revolutionary tools that offer superior industry direction of outsourcing (BPO) products and companies. The firm launched Vision, an superior and intuitive resolution that allows managers to trace agents’ efficiency and carry efficient aid. Moreover, its AeC HR skills platform, Robbyson, assists businesses by increasing engagement and efficiency with AI to mechanically estimate, suggest, and forecast outcomes.

“With a legacy of BPO products and companies management, the firm’s compelling designate proposition underpins its sustained success. AeC holds a solid space with a assorted consumer putrid, serving industry leaders of every market, along side four of the terminate 5 Brazilian unicorns and two of the terminate 5 power organizations in Brazil,” said Sebastian Menutti, industry most predominant at Frost & Sullivan.

With its buyer-centric diagram, the firm supplies consulting and highly custom-made projects for its consumers. AeC bases its operations on the core precept that its success relies on buyer satisfaction. For this design, the firm meets with consumers on the pre-sales stage to name their explicit industry requirements and challenges to construct tailor-made solutions.

“The firm acknowledges that offering a total product portfolio that aligns with broader market traits (e.g., omnichannel buyer products and companies, automation capabilities, and tools that address security challenges) is a key differentiator. Which potential that reality, it repeatedly leverages skills to spice up the efficiency and effectiveness of its products and companies, corresponding to automating processes and utilizing info analytics to design insights into stop users’ behaviors and preferences,” popular Valentina Barciasimplest practices examine analyst at Frost & Sullivan.

Every yr, Frost & Sullivan provides a Company of the 365 days award to the organization that demonstrates excellence in the case of development strategy and implementation in its field. The award acknowledges a excessive degree of innovation with products and technologies, and the following management in the case of buyer designate and market penetration.

Frost & Sullivan Most productive Practices awards glimpse companies in assorted regional and world markets for demonstrating prominent achievement and superior efficiency in management, technological innovation, buyer carrier, and strategic product development. Industry analysts examine market individuals and measure efficiency thru in-depth interviews, analyses, and extensive secondary examine to name simplest practices within the industry.

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-infamous for serving to traders, corporate leaders, and governments navigate economic adjustments and name disruptive technologies, Mega Traits, unusual industry units, and companies to action, ensuing in a continuous waft of development opportunities to power future success. Contact us: Originate the dialogue.

Contact:

Kristen Moore
P: +1 (210) 247-3823
E: [email protected]

About AeC

AeC is a Brazilian skills firm specializing in buyer family. Leading by innovation, essentially the most prominent is the warm diagram of facing folks and applying reducing-edge skills in its processes, corresponding to synthetic intelligence, cloud products and companies, analytics, and automation tools. For over 30 years, it has developed custom-made person skills solutions available within the market, serving to companies in assorted segments, corresponding to digital businesses, fintech, monetary sector, telecommunications, products and companies, retail, insurance coverage, power, and health. For the time being, AeC has more than 43,000 workers and is certified by the Substantial Living to Work Institute (GPTW).